SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-20-000027
Filing Date
2020-05-11
Accepted
2020-05-11 16:29:06
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20200331x10q.htm 10-Q 1321568
2 EX-31.1 plse-20200331xex31_1.htm EX-31.1 23630
3 EX-31.2 plse-20200331xex31_2.htm EX-31.2 22221
4 EX-32.1 plse-20200331xex32_1.htm EX-32.1 19464
  Complete submission text file 0001625101-20-000027.txt   4464659

Data Files

Seq Description Document Type Size
5 EX-101.INS plse-20200331.xml EX-101.INS 808901
6 EX-101.SCH plse-20200331.xsd EX-101.SCH 32594
7 EX-101.CAL plse-20200331_cal.xml EX-101.CAL 45634
8 EX-101.DEF plse-20200331_def.xml EX-101.DEF 106220
9 EX-101.LAB plse-20200331_lab.xml EX-101.LAB 283466
10 EX-101.PRE plse-20200331_pre.xml EX-101.PRE 242039
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 20865261
SIC: 3841 Surgical & Medical Instruments & Apparatus